Answers are grounded in this paper and cite their sources.
There have been many studies to determine the prophylactic value of pertussis vaccine in children. Lapin¹and Felton and Willard²have reviewed the literature on the subject and presented rather extensive bibliographies. A more cursory and skeptical review was published in England³and Prado and his coworkers⁴of Chile and Lewis⁵have reviewed a number of studies. It is difficult to determine what is the best vaccine product for general routine use, because the numerous studies differ from each other in so many respects. They utilize different methods of preparation of the vaccine, different methods of administration and different study procedures. The procedures differ as to environmental groups studied, as to adequacy of observation, as to method of selection and treatment of controls and differ in criteria for evaluating protection against pertussis. After full consideration of these differences, a two dose, pertussis vaccine product was
No takes yet. Share an insight, caveat, or question.
Joseph A. Bell (1948) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: